NCCR-Synapsy

The Synaptic Bases of Mental Diseases

A treatment of psychosis based on biomarkers

Conus/Do

The Centre of Psychiatric Neurosciences (CNP) schizophrenia research Unit (Prof. Kim Do Cuénod) and the CHUV General Psychiatry Department (Prof. Philippe Conus), in partnership with the Harvard Medical School of Boston (Prof. Larry Seidman), have conducted a clinical trial with Read more…


A UNIL faculty prize to Luis Alameda

Luis Alameda Unil prize 2106

Luis Alameda, CHUV psychiatrist, receives the UNIL Faculty of Biology and Medicine’s Award for his work on schizophrenia performed in collaboration with Kim Do. Luis Alameda’s publication: “Childhood sexual and physical abuse: age at exposure modulates impact on functional outcome Read more…


Regulating the brain’s redox state to prevent schizophrenia

brain redox

Kim Q. Do’s group show that cell-specific regulation of redox state balances critical periods of brain plasticity; essential as disruption of natural critical periods in brain development may be at the root of schizophrenia. Prof. Kim Q. Do’s team from Read more…


Antioxidants to reduce schizophrenia risk

apples step of oxidation

In an article published in Neuron, Kim Do and her group reveal that deficits related to schizophrenia can be corrected by protecting a specific group of vulnerable neurons from oxidative stress. Prof. Kim Do’s lab from the Centre for Psychiatric Read more…


Kim Do and Andrea Volterra new members of the SAMS

Dolterra-Do

The Senate of the Swiss Academy of Medical Sciences (SAMS) appointed Kim Do and Andrea Volterra, project leaders at the NCCR-Synapsy, as individual members of the Academy. Kim Do is associate professor at the Faculty of Biology and Medicine of Read more…